Pursuant to the terms of the Agreement, Lupin will not market its generic version of FIRDAPSE in the United States any earlier than February 25, 2035, if approved by the U.S. Food and Drug ...

Catalyst Pharmaceuticals ( NASDAQ: CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with ...

Lupin boasts a 98% Rotten Tomatoes critic score and a 79% audience score. The series was renewed by Netflix for Season 4 in ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

Either way, fans are excited to see what the cunning con-man has been up to as of late! Being that filming for Season 4 has ...

Omar Sy can be seen gallopping down the streets of Paris! Lupin has been in production for a good few months now across Paris, and the hit French show is now filming one of its biggest action ...

Ranibizumab's indications encompass the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration, and ...

Lupin has partnered with Swiss major Sandoz Group AG to market and commercialise Lupin’s biosimilar ranibizumab across ...

Sandoz will oversee commercialization of the product across the European Union (excluding Germany), Switzerland, Norway, ...

Glucagon is indicated for the treatment of severe hypoglycemia in patients with diabetes mellitus and as a diagnostic aid for ...

Lupin the 3rd: The First opens with a flashback to the 1940s, as the book’s creator attempts to have it spirited away to safety, while a group of Nazis pursue its keepers.

Prabhudas Lilladher is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 2400 in its ...